A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Vaccine

• Publication date

  2015-08-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2015.07.032PMID 26207592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Group B meningococcal vaccine: recommendations for UK use.

  2014cited by this paper
• Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis.

  2014cited by this paper
• A Randomized, Controlled, Phase 1/2 Trial of a Neisseria meningitidis Serogroup B Bivalent rLP2086 Vaccine in Healthy Children and Adolescents

  2013cited by this paper
• A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program

  2013cited by this paper
• Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.

  2013cited by this paper
• Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT

  2013cited by this paper
• Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

  2013cited by this paper
• Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).

  2013cited by this paper
• Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease

  2013cited by this paper
• The Adhesin Complex Protein (ACP) of Neisseria meningitidis Is a New Adhesin with Vaccine Potential

  2013cited by this paper
• Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.

  2012cited by this paper
• Crystal structures of receptors involved in small molecule transport across membranes.

  2012cited by this paper
• The Neisseria meningitidis Macrophage Infectivity Potentiator Protein Induces Cross-Strain Serum Bactericidal Activity and Is a Potential Serogroup B Vaccine Candidate

  2011cited by this paper
• Novel Blocking Human IgG Directed against the Pentapeptide Repeat Motifs of Neisseria meningitidis Lip/H.8 and Laz Lipoproteins

  2011cited by this paper
• Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

  2010cited by this paper
• Exploiting Antigenic Diversity for Vaccine Design

  2010cited by this paper
• BIGSdb: Scalable analysis of bacterial genome variation at the population level

  2010cited by this paper
• Immunoproteomic Analysis of the Development of Natural Immunity in Subjects Colonized by Neisseria meningitidis Reveals Potential Vaccine Candidates

  2009cited by this paper
• Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.

  2009cited by this paper
• Crystal structures and mutational analysis of the arginine-, lysine-, histidine-binding protein ArtJ from Geobacillus stearothermophilus. Implications for interactions of ArtJ with its cognate ATP-binding cassette transporter, Art(MP)2.

  2008cited by this paper
• Outer membrane vesicles from group B Neisseria meningitidis Δgna33 mutant: Proteomic and immunological comparison with detergent‐derived outer membrane vesicles

  2006cited by this paper
• A universal vaccine for serogroup B meningococcus.

  2006cited by this paper
• Proteomic Analysis of Outer Membranes and Vesicles from Wild-Type Serogroup B Neisseria meningitidis and a Lipopolysaccharide-Deficient Mutant

  2006cited by this paper
• Biochemical and Functional Characterization of Membrane Blebs Purified from Neisseria meningitidis Serogroup B*

  2005cited by this paper
• Neisseria meningitidis serogroup B: laboratory correlates of protection.

  2002cited by this paper
• Immunization with the Recombinant PorB Outer Membrane Protein Induces a Bactericidal Immune Response against Neisseria meningitidis

  2002cited by this paper
• Importance of Complement Source in Measuring Meningococcal Bactericidal Titers

  2001cited by this paper
• Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.

  2000cited by this paper
• Functional genomics of Neisseria meningitidis pathogenesis

  2000cited by this paper
• Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.

  1998cited by this paper
• A third periplasmic transport system for l‐arginine in Escherichia coli: molecular characterization of the artPIQMJ genes, arginine binding and transport

  1995cited by this paper
• Cloning and characterization of a Neisseria gene homologous to hisJ and argT of Escherichia coli and Salmonella typhimurium.

  1992cited by this paper
• A common neisserial antigen evidenced by immunization of mice with live Neisseria meningitidis

  1986cited by this paper
• Bactericidal antibodies against Neisseria gonorrhoeae elicited by Neisseria meningitidis.

  1984cited by this paper
• Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

  1983cited by this paper
• Letter: Lymphatic drainage of the brain.

  1975cited by this paper

• Biodegradation of α-solanine and α-chaconine: Insights into microbial detoxification and enzymatic deglycosylation pathways

  2025cites this paper
• Identification of vaccine candidates against rhodococcus equi by combining pangenome analysis with a reverse vaccinology approach

  2023cites this paper
• An immunoproteomics study of antisera from patients with gonorrhea identifies novel Neisseria gonorrhoeae proteins

  2023cites this paper
• The role of bacterial ATP-binding cassette (ABC) transporters in pathogenesis and virulence: Therapeutic and vaccine potential.

  2022cites this paper
• The potential utility of liposomes for Neisseria vaccines

  2021cites this paper
• Meningococcal Vaccines: Current Status and Emerging Strategies

  2018cites this paper
• Co-Expression of ORFCma with PHB Depolymerase (PhaZCma ) in Escherichia coli Induces Efficient Whole-Cell Biodegradation of Polyesters.

  2018cites this paper
• 1 Meningococcal Vaccines : Current Status and 2 Emerging Strategies 3

  2018cites this paper
• Signaling Mediated by Toll-Like Receptor 5 Sensing of Pseudomonas aeruginosa Flagellin Influences IL-1β and IL-18 Production by Primary Fibroblasts Derived from the Human Cornea

  2017cites this paper
• Novel approaches to Neisseria meningitidis vaccine design.

  2017cites this paper
• The role of structural proteomics in vaccine development: recent advances and future prospects

  2016cites this paper
• Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis

  2016cites this paper
• ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence

  2016cites this paper